Shire PLC (LSE:SHP) - Overview

Stock Report

Shire PLC SHP

Last Price
GBX4,589.50

Day Change
35.00|0.77%

As of 02/12/2016
17:11:42 GMT | GBX
Minimum 15 Minutes Delay.

Last Close4,554.50p
Day Range4,510.00 - 4,625.50
Mkt Cap41.24Bil
52-Wk Range2,707.19 - 5,562.83
Yield %0.33
ISINJE00B2QKY057
Volume2,775,765
P/E19.17
P/S6.26
P/CF17.18

Share Price

Total Returns 02/12/2016

 Chg (%)  
More ...
Shire PLC3.57 
FTSE 100 TR GBP-1.21
 
Financials
201320142015
More ...
Income Statement
Turnover3,169.523,664.344,331.22
Operating Profit1,113.511,033.20958.15
Net Profit909.371,995.88904.29
Reported EPS157.57337.83152.21
Balance Sheet
Current Assets2,581.383,330.061,522.44
Non Current Assets2,446.765,428.359,689.03
Total Assets5,047.308,758.4011,211.48
Current Liabilities1,096.361,941.522,501.59
Total Liabilities1,793.213,192.634,576.92
Total Equity3,254.095,565.776,634.56
Cash Flow
Operating Cash Flow939.752,572.911,577.46
Net Change in Cash486.58457.76-1,919.61
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20162,641.21343.4143.4113.370.3124.010.52
20173,824.89432.6625.9910.610.4127.110.59

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
31/10/2016Exercise of OptionDr. Flemming Ornskov4,028.0325210,151.00
30/09/2016PurchaseMs. Anne Minto1,288.274145,333.00
30/09/2016PurchaseMr. Bill Burns1,288.274175,372.00
30/09/2016PurchaseDr. David Ginsburg5,013.981417,070.00

Company Profile

Shire PLC is a biotech company. The Company is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines for patients with rare diseases and other select conditions.
 

Sector

Biotechnology

Market Position

12 of 1865 Companies

Index

FTSE 100 ,FTSE 350 ,S&P Europe 350 ,Eurotop 300 ,FTSE All Share

Outlook

(01/11/2016) ce - "I am highly confident about Shire's future growth prospects"

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)10.7813.1416.27
Div Yld (E)0.594.184.36
PEG (E)0.400.360.00
ROCE743.00206.9680.66
Op Mrgn34.13-17.09-14.86
EPS Grwth26.979.6525.03
Dividends
PreviousLatest
More ...
Record Date11/03/1609/09/16
Ex-Div10/03/1608/09/16
Paid12/04/1607/10/16
Amnt15.323.51

Broker Sentiment

Strong Buy0
Buy3
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMrs. Susan Kilsby
Chief Executive OfficerDr. Flemming Ornskov
Chief Financial OfficerMr. Jeff Poulton
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.